In all samples, the proportion of fragments successfully mapped to the genome exceeded 91%
71% stop taking GLP-1s by 12 months 6 74% report gastrointestinal symptoms 7 65% report NO increased exercise after starting medication 8 This is why the Noom GLP-1 Rx Program with Noom GLP-1 Companion exists
re-training on new data) must go through change control
I truly thought my metabolism was broken
Emerging Areas: Addiction, Neurodegeneration, and More The signals emerging from observational data and early trials are worth discussing, with appropriate scientific humility, because they point to a drug class that may have effects on the brain and reward system that were entirely unanticipated when these drugs were first developed
Jan 25th, 2024 Sculpting Solutions (Chapter 9) Embarking on a body sculpting journey extends beyond the capabilities of advanced machines